Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-076896
Filing Date
2022-07-01
Accepted
2022-07-01 17:01:33
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220260-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220260-3_4seq1.xml 4 4032
  Complete submission text file 0001104659-22-076896.txt   5546
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 32 BREARLY ROAD PRINCETON NJ 08540
Business Address
Sigal Charles Elliott (Reporting) CIK: 0001661908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 221062195